23andMe cuts 40% of its workforce and discontinues therapeutics division


23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the struggling genetic testing company attempts to slash costs.

from The Seattle Times The Seattle Times https://ift.tt/cqtXpeA
23andMe cuts 40% of its workforce and discontinues therapeutics division 23andMe cuts 40% of its workforce and discontinues therapeutics division Reviewed by Sudhir Malekar on November 13, 2024 Rating: 5

No comments:

Powered by Blogger.